Literature DB >> 9527053

Future of positron-emission tomography in oncology.

J E Niederhuber.   

Abstract

Mesh：

Year:  1998        PMID： 9527053      PMCID： PMC1191268          DOI： 10.1097/00000658-199803000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.

Authors:  J Kissel; G Brix; M E Bellemann; L G Strauss; A Dimitrakopoulou-Strauss; R Port; U Haberkorn; W J Lorenz
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

2.  Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

Authors:  B M Gallagher; J S Fowler; N I Gutterson; R R MacGregor; C N Wan; A P Wolf
Journal:  J Nucl Med       Date:  1978-10       Impact factor: 10.057

3.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

4.  Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.

Authors:  N Gupta; H Bradfield
Journal:  Semin Nucl Med       Date:  1996-01       Impact factor: 4.446

Review 5.  PET in oncology: will it replace the other modalities?

Authors:  C K Hoh; C Schiepers; M A Seltzer; S S Gambhir; D H Silverman; J Czernin; J Maddahi; M E Phelps
Journal:  Semin Nucl Med       Date:  1997-04       Impact factor: 4.446

6.  Positron emission tomography in the clinical evaluation of metastatic cancer.

Authors:  A J Fischman
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

7.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

Review 8.  Colorectal cancer. Radiologic staging.

Authors:  R F Thoeni
Journal:  Radiol Clin North Am       Date:  1997-03       Impact factor: 2.303

9.  Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.

Authors:  F L Flanagan; F Dehdashti; O A Ogunbiyi; I J Kodner; B A Siegel
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

Review 10.  New imaging techniques in colorectal cancer.

Authors:  M Tempero; R Brand; K Holdeman; A Matamoros
Journal:  Semin Oncol       Date:  1995-10       Impact factor: 4.929
View more
  1 in total

Review 1.  18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Authors:  D M Rose; D Delbeke; R D Beauchamp; W C Chapman; M P Sandler; K W Sharp; W O Richards; J K Wright; M E Frexes; C W Pinson; S D Leach
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.